Reference articles on history, science, culture and more
Surprise meSurprise meSubscribe
Encyclopedia

BFAI

Chemical compound

Wikipedia contributorsAdapted for Fathomly · View authors
1 min read
Source updated November 18, 2025
Image credit is listed at the end of this article.

BFAI, also known as 5,6-benzofuranyl-2-aminoindane, is a drug of the 2-aminoindane family that acts as a serotonin releasing agent (SSRA) and may produce entactogenic effects in humans, which may be useful for psychotherapeutic applications. It is closely related to MDAI but with the benzodioxole ring system replaced by benzofuran. The drug was patented by Matthew Baggott and Tactogen in 2022.

Watch videos about BFAIExplainers and documentaries on YouTube (opens in a new tab)

Sources and credits

This article is adapted from the Wikipedia article “BFAI”, written by its contributors and licensed under CC BY-SA 4.0. Fathomly has changed the layout, removed citation markers, navigation and maintenance notices, and adjusted punctuation. This adapted version is shared under the same license. For references, see the original article.

Images, from Wikimedia Commons:

Fathomly is not affiliated with or endorsed by the Wikimedia Foundation. Spotted a problem? Tell us.

Continue exploring

Related topics

Substituted 2-aminoindane

A substituted 2-aminoindane is a derivative of 2-aminoindane with one or more chemical substituents. They are cyclized phenethylamines and are structurally related to amphetamines like amphetamine and MDMA. Many 2-aminoindanes are known to act as monoamine releasing agents and/or receptor modulators.

6-APB

6-APB, also known as 6-benzofuran, is an entactogen of the phenethylamine, amphetamine, and benzofuran families. 6-APB and related drugs are sometimes informally called "Benzofury" in media reports.

5-MAPB

5-MAPB, also known as 5-benzofuran, as well as by nicknames such as "MDMA 2.0" and "Gas Station Molly", is an entactogen of the phenethylamine, amphetamine, and benzofuran families related to MDMA ("Ecstasy"). It is an analogue of MDMA in which one of the oxygen atoms of the benzodioxole ring has been replaced with a carbon atom.